BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 2803466)

  • 1. Synthesis of polyamine-linked bis-daunomycin hydrazones and their interaction with DNA.
    Hook RJ; Phillips DR; Reiss JA
    Anticancer Drug Des; 1989 Oct; 4(3):173-90. PubMed ID: 2803466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elucidation of the DNA sequence preferences of daunomycin.
    Skorobogaty A; White RJ; Phillips DR; Reiss JA
    Drug Des Deliv; 1988 Jul; 3(2):125-51. PubMed ID: 2855576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The synthesis, stability and biological activity of bis-intercalating bis-daunomycin hydrazones.
    Phillips DR; Baguley BC; Brownlee RT; Cacioli P; Chandler CJ; Kyratzis I; Reiss JA; Scourides PA
    Drug Des Deliv; 1990 Mar; 5(3):203-19. PubMed ID: 1670502
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bis-daunomycin hydrazones: interactions with DNA.
    Phillips DR; Brownlee RT; Reiss JA; Scourides PA
    Invest New Drugs; 1992 Jul; 10(2):79-88. PubMed ID: 1500269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of anthracyclines and synthetic hexanucleotides. Structural factors influencing sequence specificity.
    Rizzo V; Battistini C; Vigevani A; Sacchi N; Razzano G; Arcamone F; Garbesi A; Colonna FP; Capobianco M; Tondelli L
    J Mol Recognit; 1989 Nov; 2(3):132-41. PubMed ID: 2636902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA sequence recognition by bispyrazinonaphthalimides antitumor agents.
    Carrasco C; Joubert A; Tardy C; Maestre N; Cacho M; BraƱa MF; Bailly C
    Biochemistry; 2003 Oct; 42(40):11751-61. PubMed ID: 14529286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding of two novel bisdaunorubicins to DNA studied by NMR spectroscopy.
    Robinson H; Priebe W; Chaires JB; Wang AH
    Biochemistry; 1997 Jul; 36(29):8663-70. PubMed ID: 9289011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The DNA-association and biological activity of a new bis(14-thiadaunomycin).
    Skorobogaty A; Brownlee RT; Chandler CJ; Kyratzis I; Phillips DR; Reiss JA; Trist H
    Anticancer Drug Des; 1988 Jun; 3(1):41-56. PubMed ID: 3382506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Daunomycin-DNA dissociation kinetics.
    Phillips DR; Greif PC; Boston RC
    Mol Pharmacol; 1988 Feb; 33(2):225-30. PubMed ID: 3340082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural requirements for the formation of anthracycline-DNA adducts.
    Cutts SM; Parker BS; Swift LP; Kimura KI; Phillips DR
    Anticancer Drug Des; 2000 Oct; 15(5):373-86. PubMed ID: 11354313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design, synthesis, and biological evaluation of DNA sequence and minor groove selective alkylating agents.
    Lee M; Rhodes AL; Wyatt MD; Forrow S; Hartley JA
    Anticancer Drug Des; 1993 Jun; 8(3):173-92. PubMed ID: 8517912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interactions of the antitumor agents mitoxantrone and bisantrene with deoxyribonucleic acids studied by electron microscopy.
    Lown JW; Hanstock CC; Bradley RD; Scraba DG
    Mol Pharmacol; 1984 Jan; 25(1):178-84. PubMed ID: 6708933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of DNA-intercalating antitumor agents with adrenoceptors.
    Adams A; Jarrott B; Elmes BC; Denny WA; Wakelin LP
    Mol Pharmacol; 1985 Apr; 27(4):480-91. PubMed ID: 2984540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological properties of N4- and N1,N8-spermidine derivatives in cultured L1210 leukemia cells.
    Porter CW; Cavanaugh PF; Stolowich N; Ganis B; Kelly E; Bergeron RJ
    Cancer Res; 1985 May; 45(5):2050-7. PubMed ID: 3921235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetic and equilibrium studies of the interaction of amsacrine and anilino ring-substituted analogues with DNA.
    Denny WA; Wakelin LP
    Cancer Res; 1986 Apr; 46(4 Pt 1):1717-21. PubMed ID: 3753896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of a DNA-bisdaunomycin complex.
    Hu GG; Shui X; Leng F; Priebe W; Chaires JB; Williams LD
    Biochemistry; 1997 May; 36(20):5940-6. PubMed ID: 9166763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential DNA recognition by the enantiomers of 1-Rh(MGP)2 phi: a combination of shape selection and direct readout.
    Franklin SJ; Barton JK
    Biochemistry; 1998 Nov; 37(46):16093-105. PubMed ID: 9819202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, characterization, antioxidant activity and DNA-binding studies of two rare earth(III) complexes with naringenin-2-hydroxy benzoyl hydrazone ligand.
    Li TR; Yang ZY; Wang BD; Qin DD
    Eur J Med Chem; 2008 Aug; 43(8):1688-95. PubMed ID: 18037194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper-activated DNA photocleavage by a pyridine-linked bis-acridine intercalator.
    Fernandez MJ; Wilson B; Palacios M; Rodrigo MM; Grant KB; Lorente A
    Bioconjug Chem; 2007; 18(1):121-9. PubMed ID: 17226964
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.